TMCnet News
Shapiro Haber & Urmy LLP Filed the Only Securities Fraud Class Action Lawsuit Brought Against InVivo Therapeutics Holdings Corp.BOSTON --(Business Wire)-- The Boston, MA law firm Shapiro Haber & Urmy LLP wishes to notify InVivo investors that it filed the only class action securities fraud suit that has been brought against InVivo Therapeutics Holdings Corp. ("InVivo") (OTCBB: NVIV), a Cambridge, MA company, and its former Chairman and CEO for violations of federal securities laws. The firm filed the complaint on July 31, 2014 in the United States District Court for the District of Massachusetts, entitled Battle Construction Co., Inc. v. InVivo Therapeutics Holdings Corp., et al., C.A. No. 14-cv-13180. Numerous press releases have been issued by different law firms announcing the suit, but Shapiro Haber & Urmy LLP is the only firm that has conducted a careful investigation and filed suitto recover money for investors. The Complaint alleges that the Defendants made false and misleading statements about the FDA's approval of a clinical trial and the time for completion of the trial and submission of data to the FDA. The Complaint alleges that these misstatements and omissions by Defendants misrepresented and/or omitted material facts to the investing public, in violation of Sections 10(b) and 20(a) of the Securities Exchange Act. The class action is brought on behalf of all persons and entities who purchased common stock of InVivo during the period from April 5, 2013 through August 26, 2013. If you are interested in joining the suit, or you wish to register with the firm as a member of the class, please contact the firm at the telephone numbers below or by email. More information about the law firm and its qualifications is available at www.shulaw.com. The firm has extensive experience litigating securities fraud class actions and has the highest rating of AV from Martindale Hubbell. Partner Thomas Shapiro, who prepared the InVivo complaint, has been recognized as one of the top 100 lawyers in New England.
|
